MedTrace Logo

Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy

NCT00355680 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-02-11

No results posted yet for this study

Summary

To Demonstrate that indigenous green laser produces similar treatment effect on the retina when compared with already available green laser.

Conditions

Interventions

DEVICE

Green Laser (Aurolas, Aurolab)

Green laser developed by Aurolab

DEVICE

Green Laser (Iridex)

Already available green laser

Sponsors & Collaborators

  • Raja Ramanna Centre for Advanced Technology (RRCAT)

    collaborator UNKNOWN

  • Aurolab

    lead OTHER

Principal Investigators

  • Chandra Mohan, MS · Arvind Eye Hospital, Madurai

  • Dhananjay Shukla, MS · Aravind Eye Hospital

  • Naresh Babu, MS, FNB · Aravind Eye Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2006-07-31
Completion
2006-07-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00355680 on ClinicalTrials.gov